All In MedTech

Device Trial Radar · NCT03312010

High Frequency PNS Stimulation Study for Back and Leg Pain

A European, Prospective, Multi-Center, Double-Blind, Randomized, Controlled, Clinical Trial Investigating the Effects of High Frequency Peripheral Nerve Stimulation (PNS) in the Treatment of Chronic Back Pain

Last checked: Nov 20, 2026Latest source record: Nov 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

38

Actual

Start

Mar 1, 2018

Primary completion

Aug 1, 2019

Study completion Dec 1, 2022

Sponsor

Lead sponsor
Curonix LLCNot on our public-company list
Sponsor type
Industry
Collaborators
AZ Delta; GZA Ziekenhuizen Campus Sint-Augustinus
First posted
Oct 17, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, double blinded, randomized, clinical study investigating the effects of high frequency PNS for the treatment of chronic back or back and leg pain.

Conditions

  • Chronic Back Pain
  • Chronic Back and Leg Pain

Interventions

  • PNS HFDevice

    A needle and catheter is carefully inserted near your spinal column. The stimulator is then placed through the catheter and directed towards the T9 proximal peripheral nerves. The proximal end of the stimulator is then sutured underneath the skin of your back to the fascia to prevent migration.

  • PNS ShamDevice

    A needle and catheter is carefully inserted near your spinal column. The stimulator is then placed through the catheter and directed towards the T9 proximal peripheral nerves. The proximal end of the stimulator is then sutured underneath the skin of your back to the fascia to prevent migration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Responder rateTime frame: 1 month post-implant

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • AZ Delta

    Roeselare, Belgium

  • GZA Sint-Augustinus

    Wilrijk, Antwerpen, Belgium

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.